论文部分内容阅读
来昔决南钐[153Sm]（153Sm-EDTMP）注射液能有效缓解各种骨转移癌及原发性骨癌所致的疼痛。该种放射性治疗新药具有药效高、副作用小、使用方便等特点。 同位素研究所研制的来昔决南钐[153Sm]注射液曾获得国际原子能机构的技术援助,并列入国家“九五”科技攻关项目。在完成临床试验及中国药品生物制品检定所检验合格后,又经过了国家药品监督管理局药品审评中心的技术评审,最后获得国家药品监督管理局批准的
Samadhi Samarium [153Sm] (153Sm-EDTMP) injection can effectively relieve the pain caused by various bone metastases and primary bone cancer. The new radiopharmaceuticals have the characteristics of high efficacy, little side effects and convenient use. The Institute of Isotope Institute of the former South Samarium [153Sm] injection has access to the International Atomic Energy Agency technical assistance, and included in the national “Ninth Five-Year” scientific and technological projects. After the completion of clinical trials and testing of the Chinese pharmaceutical and biological products pass the test, but also after the State Drug Administration Center for Drug Evaluation of the technical review, the final approval of the State Drug Administration